Video | Proactive Investors – Orthocell highlights potential for CelGro in treatment of lymphedema

3 August 2021
Posted in Media, Video
3 August 2021 Orthocell

Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro™ with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).